Showing results (191-200 of 213) with videos related to
Sort By:
Pageof 22
Digestive Diseases and Sciences|October 17, 2018
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.Frontiers in Aging Neuroscience|February 3, 2025
Application of the Uniform Data Set version 3 tele-adapted test battery (T-cog) for remote cognitive assessment preoperatively in older adultsMika M Rockholt, Rachel R Wu, Elaine Zhu, et al.Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|February 5, 2013
Use of biologics for inflammatory bowel disease in Hong Kong: consensus statementW K Leung, Siew C Ng, Dorothy K L Chow, et al.Journal of Gastroenterology and Hepatology|May 6, 2017
Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosisLung-Yi Mak, Siew C Ng, Irene O L Wong, et al.Digestive Diseases and Sciences|August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.Molecular Genetics and Metabolism|January 9, 2010
Biochemical and molecular characterization of tyrosine hydroxylase deficiency in Hong Kong ChineseC M Mak, C W Lam, T S Siu, et al.Scandinavian Journal of Gastroenterology|March 3, 2020
Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort studyJoyce Wing Yan Mak, Jacqueline So, Whitney Tang, et al.Journal of Crohn'S & Colitis|August 31, 2018
Significant Medical and Surgical Morbidity in Perianal Crohn's Disease: Results from a Territory-Wide StudyWing Yan Mak, Oi Sze Mak, Choon Kin Lee, et al.Alimentary Pharmacology & Therapeutics|October 23, 2019
Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's diseaseJoyce Wing Yan Mak, Whitney Tang, Terry Cheuk Fung Yip, et al.The Journal of Clinical Investigation|July 14, 2022
Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasmaPaula Saá, Rebecca V Fink, Sonia Bakkour, et al.Pageof 22